Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase Ib/II Trial of coPANlisib in Combination With Trastuzumab in HER2-positive Breast Cancer. (Panther Study) (Panther)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02705859
Recruitment Status : Recruiting
First Posted : March 11, 2016
Last Update Posted : August 2, 2019
Sponsor:
Information provided by (Responsible Party):
Cancer Trials Ireland

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2022